Inhibrx Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $180.8M
Liabilities Breakdown FY2024
Total Liabilities: $47.2M
Asset Breakdown
Total Assets: $180.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $152.6M | 84.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.2M | 3.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $22.0M | 12.2% |
Liabilities Breakdown
Total Liabilities: $47.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.2M | 19.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.9M | 80.4% |